highly significantP < 0.001
The highly significant effect on FI in trial 2 ( P < 0.001 for the grower, finisher, and entire 35-day period) was in contrast to the absence of a treatment effect of OxBC in trial 1.
The highly significant effect on FI in trial 2 ( P < 0.001 for the grower, finisher, and entire 35-day period) was in contrast to the absence of a treatment effect of OxBC in trial 1.
However, FI in the 2 ppm OxBC group at day 31 was numerically higher than FI in both control and medicated groups and for the 1 ppm and 5 ppm OxBC groups, and the difference approached significance ( P = 0.07).